NCT00000600

Brief Summary

This study will evaluate the effects of vitamin E supplementation in retarding the progression of common carotid artery intima-media thickening in African Americans.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Jun 1995

Longer than P75 for phase_2 cardiovascular-diseases

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 1995

Completed
4.4 years until next milestone

First Submitted

Initial submission to the registry

October 27, 1999

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 28, 1999

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2000

Completed
Last Updated

December 13, 2013

Status Verified

October 1, 2006

First QC Date

October 27, 1999

Last Update Submit

December 12, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • rate of change in average common carotid artery intima-media thickness (measured over 24 months)

Interventions

Eligibility Criteria

Age35 Years - 59 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • African American

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cardiovascular DiseasesCarotid Artery DiseasesIntracranial ArteriosclerosisCerebrovascular DisordersHeart DiseasesVascular DiseasesAtherosclerosis

Interventions

Vitamin EAscorbic Acid

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesIntracranial Arterial DiseasesArteriosclerosisArterial Occlusive Diseases

Intervention Hierarchy (Ancestors)

BenzopyransPyransHeterocyclic Compounds, 1-RingHeterocyclic CompoundsHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingSugar AcidsAcids, AcyclicCarboxylic AcidsOrganic ChemicalsHydroxy AcidsCarbohydrates

Study Officials

  • James H. Dwyer, III

    University of Southern California

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Purpose
PREVENTION
Sponsor Type
NIH

Study Record Dates

First Submitted

October 27, 1999

First Posted

October 28, 1999

Study Start

June 1, 1995

Study Completion

May 1, 2000

Last Updated

December 13, 2013

Record last verified: 2006-10